1. Volume 55, Issue 3, Pages 1063-1071 (March 1999)
Circulating vascular endothelial growth factor is not increased during relapses of steroid- sensitive nephrotic syndrome 
Nicholas J.A. Webb, Carolyn J. Watson, I.A.N.S.D. Roberts, Martyn J. Bottomley, Caroline A. Jones, Malcolm A. Lewis, Robert J. Postlethwaite, Paul E.C. Brenchley 
Kidney International 
Volume 55, Issue 3, Pages (March 1999)
DOI: /j x
Copyright © 1999 International Society of Nephrology Terms and Conditions

2. Figure 1
(A) Plasma vascular endothelial growth factor (VEGF) levels in children with steroid-sensitive nephrotic syndrome (in relapse and remission) and age- and sex-matched normal controls. P = 0.295, Kruskal–Wallis test. (B) Urinary VEGF/Cr ratios in children with steroid-sensitive nephrotic syndrome (in relapse and remission) and age- and sex-matched normal controls. P = 0.632, Kruskal–Wallis test. Horizontal bars denote median values.
Kidney International  , DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

3. Figure 2
(A) Blood pressure (mean ± SEM) in Sprague-Dawley rats prior to, during, and for 60 minutes after the administration of rVEGF165 (50 μg; N = 5) or 0.9% saline (N = 5). Symbols are: (▪) VEGF-administered animals; (▴) saline-administered animals. (B) Urine output (mean ± SEM) in Sprague-Dawley rats prior to and following administration of rVEGF165 (50 μg; N = 5) or 0.9% saline (N = 5). (C) Urinary protein excretion (mean ± SEM) by Sprague-Dawley rats following administration of rVEGF165 (50 μg; N = 5) or 0.9% saline (N = 5).
Kidney International  , DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

4. Figure 3
(A) Urine output (mean ± SEM) in Sprague-Dawley rats prior to and following the administration of rVEGF165 (50 μg; N = 4) or 0.9% saline (N = 4). Symbols are: (▪) VEGF-administered animals; (▴) saline-administered animals. (B) Urinary protein excretion (mean ± SEM) in Sprague-Dawley rats prior to and following administration of rVEGF165 (50 μg; N = 4) or 0.9% saline (N = 4).
Kidney International  , DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

5. Kidney International 1999 55, 1063-1071DOI: (10. 1046/j. 1523-1755
Kidney International  , DOI: ( /j x)
Copyright © 1999 International Society of Nephrology Terms and Conditions